Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 84 Colorectal Neoplasms 42 Rectal Neoplasms 40 Carcinoma, Non-Small-Cell Lung 27 Esophageal Neoplasms 24 Esophageal Squamous Cell Carcinoma 23 Stomach Neoplasms 19 Lung Neoplasms 19 Squamous Cell Carcinoma of Head and Neck 17 Colonic Neoplasms 17 Pancreatic Neoplasms 15 Adenocarcinoma Of Esophagus 15 Sarcoma 14 Prostatic Neoplasms 13 Neoplasm Metastasis 13 Neoplasms 12 Head and Neck Neoplasms 12 Ovarian Neoplasms 11 Carcinoma, Hepatocellular 11 Inflammatory Breast Neoplasms 9 Uterine Cervical Neoplasms 8 Urinary Bladder Neoplasms 8 Osteosarcoma 8 Fallopian Tube Neoplasms 8 Central Nervous System Neoplasms 8 Carcinoma, Intraductal, Noninfiltrating 8 Kidney Neoplasms 7 Multiple Myeloma 6 Glioblastoma 6 Carcinoma, Renal Cell 6

Interventions

Neoadjuvant Therapy 1 Lapatinib 1 Epirubicin 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Capecitabine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Oesophagogastric Cancer × Neoadjuvant Therapy × Clear all

NCT00450203 2016-12-01

ST03

Medical Research Council

Phase 2/3 Unknown

Gastrointestinal

Oesophagogastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡